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Abstract
Introduction: Parkinsonism puts a high direct cost burden on both patient and caregiver. Several reports of drug-
induced parkinsonism have been published, but to the best of our knowledge, there has not been any report of
quinine or halothane inducing parkinsonism.
Case presentation: We describe two cases of parkinsonism possibly caused by adverse drug reaction to quinine in
a 29-year-old black Nigerian woman and to halothane in a 36-year-old black Hausa (Nigerian) man who received it
as general anaesthesia for appendicectomy in our teaching hospital.
Conclusion: These are two unusual cases of parkinsonism caused by adverse drug reactions to high-dose quinine
and to halothane as general anaesthesia. We consider that these two cases are important in bringing this potential
side-effect to the attention of both pharmacologists and primary care physicians as these are two of the most
commonly used medications in our clinics. We conclude that parkinsonism should be included among the adverse
drug reactions to high-dose quinine and halothane general anaesthetic.
Introduction
The most common cause of parkinsonism is Parkinson’s
Disease (PD), accounting for approximately 77.7% of
cases, followed by parkinsonism-plus syndrome (12.2%).
Secondary causes such as drugs, trauma, vascular condi-
tions, acquired immunodeficiency disease and toxins
make up around 8.2%, and the remaining 0.6% of cases
are classified as Heredodegenerative parkinsonism [1].
Quinine was the first antimalarial drug available, which
has been in use since the 17th century [2]. Quinine is a
natural white crystalline alkaloid with antipyretic effects.
It is a stereoisomer of quinidine, which has an antiar-
rhythmic effect. Side effects of quinine include cinchon-
ism, pulmonary oedema, abnormal heart rhythms and
hearing impairment [3]. Contrary to popular belief, qui-
nine is an ineffective abortifacient, and is recommended
by World Health Organization (WHO) for use in preg-
nancy [4]. The mechanism of action of quinine is still
elusive but the most popular hypothesis is inhibition of
hemozoin biocrystallization leading to formation of cyto-
toxic heme, which accumulates within the malaria para-
sites and causes their death [5].
Halothane is an inhalational anaesthetic agent, chemi-
cally designated 2-bromo-2-chloro-1,1,1-trifluoroethane.
Halothane anaesthesia augments the action of nondepo-
larizing skeletal muscle relaxants and ganglionic block-
ing agents, and is also a potent uterine relaxant [6]. The
side effects include hepatic necrosis, cardiac and respira-
tory arrest, hypotension, cardiac arrhythmias, hyperpyr-
exia, shivering, nausea and emesis [6].
Several drugs and toxins have been reported to cause
parkinsonism, but to the best of our knowledge, there
has been no report of parkinsonism induced by quinine
or halothane. The aetiology of PD is still elusive, although
a combination of environmental and genetic factors is
implicated [7]. The anatomy of the basal ganglia consists
of group of nuclei situated in the deep part of the cere-
brum and upper part of the brain stem. The neurophy-
siological changes in the basal ganglia responsible for
parkinsonism are mainly neuronal loss in the substantia
nigra with consequent dopamine depletion in the stria-
tum [8]. Evidence is accumulating about mechanisms by
which drugs and toxins cause parkinsonism. They act on
particular steps in the formation, storage in presynaptic
vesicles, release, uptake, catabolism and re-synthesis of
neurotransmitters such as dopamine, serotonin, norepi-
nephrine, acetylcholine and other catecholamines [9].
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Patient 1
A 29-year-old Nigerian Edo woman, presented with a
five-day history of tremor of her fingers and head at rest,
with associated drooling of saliva from her mouth. There
was no history of fever, vomiting, headache, dyspeptic
symptoms or any other neurological symptoms, although
she reported dizziness. She had not used any drugs in the
preceding six weeks except for quinine tablets. She
reported having had amenorrhea for eight weeks, and
believing that she was pregnant, she had taken some
tablets of quinine to terminate the pregnancy. She
reported having vaginal bleeding five days after ingestion
of six tablets of quinine. She had no family history of PD.
On physical examination, our patient was found to
have mask-like facies, and her speech was monotonous
and slightly slurred. She was extremely slow in carrying
out all motor activities. Results of neurological examina-
t i o n sw e r ee s s e n t i a l l yn o r m a le x c e p tf o rt h ep r e s e n c eo f
cogwheel and global muscular rigidity. Results of blood
chemistry and haematological studies were normal, and
serum syphilis and human immunodeficiency virus (HIV)
testing were negative. Chest radiography and brain mag-
netic resonance imaging were essentially normal. A preg-
nancy test was positive and a pelvic ultrasound scan
showed a bulky uterus with product of conception.
Based on the clinical signs and symptoms, a diagnosis
of drug-induced Parkinsonian syndrome was made. We
started our patient on low-dose levodopa/carbidopa
100/25 mg tablets twice daily. After five days of treat-
ment, all the symptoms had disappeared. The patient
recovered completely and had no recurrence of symp-
toms during follow-up of 30 weeks after discontinuing
treatment.
Patient 2
A 36-year-old Nigerian Hausa man who had undergone
an appendicectomy was referred to our neurology unit
with tremor at rest and bradykinesia. The surgery had
been uneventful, and our patient had not taken any
medication likely to affect the central nervous system
for six weeks before his surgery. His only medication
had been the halothane that was used as general anaes-
thetic for his appendicectomy, along with preoperative
medications consisting of 5 mg diazepam injections,
1 mg starting dose of atropine, and 50 mg of pethidine.
Postoperatively, he received intravenous ampicillin and
cloxacillin at a dose of 1 g every six hours for one week,
and 50 mg of tramadol every 12 hours for five days. He
has no family history of PD.
A careful neurological evaluation revealed asymmetri-
cal rigidity, affecting the rig h ts i d em o r et h a nt h el e f t ,
with hypokinesia and tremor. Laboratory investigations,
including full blood count, electrolytes and urea, and
testing for malaria parasite, HIV and syphilis were
essentially normal.
Our patient was diagnosed with drug-induced parkin-
sonism (DIP) and started on levodopa/carbidopa
(250 mg) daily. After three days of treatment, the symp-
toms resolved completely and six weeks after he
remained healthy.
Discussion
Drugs are the most common causes of parkinsonism in
the general population, and are generally drugs that
block postsynaptic dopamine receptors or deplete pre-
synaptic dopamine. Several drugs have been implicated
as a cause of parkinsonism, including dopamine
antagonists such as prochlorperazine for giddiness,
metoclopramide for dyspepsia and chlorpromazine for
bipolar depression; calcium-channel blockers such as
flunarizine and Cinnarizine; and sodium valproate for
epilepsy and migraine headache. Some of these medi-
cations may also be adulterated because of increased
access via the internet [10].
Chabolla et al. reported that DIP is indistinguishable
from PD [11]; however, Susatia and Fernandez contra-
dicted this in their recent review, suggesting that DIP
can be distinguished from PD because tremor and gait
instability are less prominent in DIP [12]. Treatment of
DIP involves discontinuation of the offending drugs,
which usually promotes remission of the Parkinsonian
syndrome within a short time, although parkinsonism
may sometimes persist. Such patients may have subclini-
cal parkinsonism and require dopaminergic treatment as
with our two patients. PD is usually irreversible, but
DIP is reversible [13]. MRI scans usually give normal
results in DIP, as in our first patient; our second patient
could not afford to undergo neuroimaging studies.
The clinical findings in our two patients are unusual
adverse reactions of quinine or halothane administra-
tion. The response to levodopa was an indication of loss
of dopamine in the dopaminergic systems, which may
explain the remarkable effects of levodopa in these two
cases.
The effects of general anaesthesia were for many years
attributed to changes in the physical chemistry of neu-
rons. More recently, it has been linked to ligand-gated
ion channels and to alterations in neurotransmitter
function. Inhalational anaesthesia has been known to
inhibit brainstem activity to the extent that pupillary
reflexes and corneal reflex is eliminated with complete
return to normal by the time the patient has recovered
sufficiently to talk [14]. Nevertheless, Adachi et al.w e r e
able to show that halothane causes decrease in dopami-
nergic activity in a rat brain model [15].
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alters the physicochemical properties of the cell mem-
brane and thus impairs the activities of the membrane
receptor systems that regulate ion channels, particularly
the chloride and calcium channels [16]. However, Freed-
man et al. have shown that quinine blocks the K+ chan-
nels in rat corpus striatum and that this blockade may be
attained in human brain at an antimalarial dosage of
quinine [17].
Conclusion
In conclusion, the side effects of quinine and of inhala-
tional anaesthetics such as halothane can now be broa-
dened to rarely include parkinsonism, and should be
considered in patients presenting with similar symptoms.
As with other symptoms more commonly associated
with this condition, these may resolve after discontinua-
tion of the offending drugs or administration of levodopa
for persistent symptoms. Further studies are warranted
to elucidate the relationship and the mechanism by
which halothane and quinine can cause parkinsonism.
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